The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; A review
作者： Ferry A.L.M. Eskens , Jaap Verweij
DOI: 10.1016/J.EJCA.2006.09.015
关键词:
摘要: … on the lymphatic endothelium initiates lymphangiogenesis. … stimulus for local hypoxia inducible transcription factor-alfa (HIF-1α) … Dual role of vascular endothelial growth factor in hepatic …
elsevier.com
sci-hub.se 参考文章(97)
H. Wakelee, A. A. Adjei, H. Keer, J. Halsey, L. Hanson, J. Reid, S. Hutchison, J. Piens, S. Lacy, B. I. Sikic, A phase I dose-escalation and pharmacokinetic (PK) study of a novel multiple-targeted receptor tyrosine kinase (RTK) inhibitor, XL647, in patients with advanced solid malignancies Journal of Clinical Oncology. ,vol. 23, pp. 3142- 3142 ,(2005) , 10.1200/JCO.2005.23.16_SUPPL.3142
Justin Tatch Moore, Open colorings, the continuum and the second uncountable cardinal Proceedings of the American Mathematical Society. ,vol. 130, pp. 2753- 2759 ,(2002) , 10.1090/S0002-9939-02-06376-1
Renee Risingsong, Gordon W. Gribble, Julie B. Stimmel, Timothy M. Willson, Evan Rosen, Nanjoo Suh, Yukiko Honda, Andrew E. Place, Michael B. Sporn, Tadashi Honda, Lisa M. Leesnitzer, Charlotte R. Williams, The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. Clinical Cancer Research. ,vol. 9, pp. 2798- 2806 ,(2003)
Marc D. Basson, Gut mucosal healing: is the science relevant? American Journal of Pathology. ,vol. 161, pp. 1101- 1105 ,(2002) , 10.1016/S0002-9440(10)64385-4
Cristiana Sessa, Lucia Viganò, Giacomo Grasselli, Josè Trigo, Irene Marimon, Anna Lladò, Alberta Locatelli, Nicoletta Ielmini, Silvia Marsoni, Luca Gianni, Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing. European Journal of Cancer. ,vol. 42, pp. 171- 178 ,(2006) , 10.1016/J.EJCA.2005.09.033
Gordon C. Jayson, Clive Mulatero, Malcolm Ranson, Jamal Zweit, Alan Jackson, Lynn Broughton, John Wagstaff, Leif Hakansson, Gerard Groenewegen, Jeremy Lawrance, Meina Tang, Linda Wauk, Dan Levitt, Sandrine Marreaud, Frederic F. Lehmann, Manfred Herold, Heinz Zwierzina, Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer European Journal of Cancer. ,vol. 41, pp. 555- 563 ,(2005) , 10.1016/J.EJCA.2004.11.021
Eduardo Nagore, Amelia Insa, Onofre Sanmart??n, Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management. American Journal of Clinical Dermatology. ,vol. 1, pp. 225- 234 ,(2000) , 10.2165/00128071-200001040-00004
Catherine Wheeler, Hironobu Minami, Hiromichi Ebi, Makoto Tahara, Yasutsuna Sasaki, Noboru Yamamoto, Yasuhide Yamada, Tomohide Tamura, Nagahiro Saijo, P-359 Results from a phase I study of the oral VEGF receptor tyrosine kinase inhibitor ZD6474, in patients with solid tumors Lung Cancer. ,vol. 41, ,(2003) , 10.1016/S0169-5002(03)92327-0
Jennifer LeCouter, Dirk R Moritz, Bing Li, Gail Lewis Phillips, Xiao Huan Liang, Hans-Peter Gerber, Kenneth J Hillan, Napoleone Ferrara, None, Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1 Science. ,vol. 299, pp. 890- 893 ,(2003) , 10.1126/SCIENCE.1079562
A. Brockington, C. Lewis, S. Wharton, P. J. Shaw, Vascular endothelial growth factor and the nervous system. Neuropathology and Applied Neurobiology. ,vol. 30, pp. 427- 446 ,(2004) , 10.1111/J.1365-2990.2004.00600.X